4.7 Article

Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease

Hae-Ki Min et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)

Article Immunology

CD68 acts as a major gateway for malaria sporozoite liver infection

Sung-Jae Cha et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Gastroenterology & Hepatology

Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease

Christopher Leung et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Oncology

IGF binding proteins in cancer: mechanistic and clinical insights

Robert C. Baxter

NATURE REVIEWS CANCER (2014)

Article Biochemistry & Molecular Biology

Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor

Jianwei Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Review Gastroenterology & Hepatology

Immune and inflammatory pathways in NASH

Michal Ganz et al.

HEPATOLOGY INTERNATIONAL (2013)

Article Biochemistry & Molecular Biology

Minor Role of Mitochondrial Respiration for Fatty-Acid Induced Insulin Secretion

Nadja Schulz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Gastroenterology & Hepatology

Therapeutic strategies in inflammasome mediated diseases of the liver

Rafaz Hoque et al.

JOURNAL OF HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

Quentin M. Anstee et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Lipotoxicity in NASH

Michael Fuchs et al.

JOURNAL OF HEPATOLOGY (2012)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

Gyoergy Baffy et al.

JOURNAL OF HEPATOLOGY (2012)

Article Oncology

IGFBP-3 Is a Metastasis Suppression Gene in Prostate Cancer

Hemal H. Mehta et al.

CANCER RESEARCH (2011)

Article Hematology

Circulating Insulin-Like Growth Factor-1 and Its Binding Protein-3 Metabolic and Genetic Correlates in the Community

Carolyn S. P. Lam et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer

Angela R. Ingermann et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Medicine, General & Internal

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.

Arun J. Sanyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemistry & Molecular Biology

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

I. Ibanez de Caceres et al.

ONCOGENE (2010)

Review Endocrinology & Metabolism

Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease

Sherryline Jogie-Brahim et al.

ENDOCRINE REVIEWS (2009)

Article Gastroenterology & Hepatology

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

Curtis K. Argo et al.

JOURNAL OF HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal

Naim Alkhouri et al.

Expert Review of Gastroenterology & Hepatology (2009)

Article Biochemistry & Molecular Biology

Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: Role in modulation of RAR-signaling

Lynette J. Schedlich et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)

Article Gastroenterology & Hepatology

Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes

Swati joshi-Barve et al.

HEPATOLOGY (2007)

Article Pathology

Pathology of fatty liver disease

Elizabeth M. Brunt

MODERN PATHOLOGY (2007)

Article Gastroenterology & Hepatology

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Mattias Ekstedt et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

John Willy Haukeland et al.

JOURNAL OF HEPATOLOGY (2006)

Article Endocrinology & Metabolism

Nonalcoholic fatty liver disease - A feature of the metabolic syndrome

G Marchesini et al.

DIABETES (2001)

Review Pathology

Signalling pathways involved in antiproliferative effects of IGFBP-3: a review

RC Baxter

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)

Article Gastroenterology & Hepatology

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

AJ Sanyal et al.

GASTROENTEROLOGY (2001)